As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Nanomedicine Market: By Product Type: Therapeutics, Regenerative Medicine, In-Vitro Diagnostics, In-Vivo Diagnostics, Vaccines; By Application: Clinical Oncology, Others; By Nanomolecule Type; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Nanomedicine Market Outlook

The global nanomedicine market is being aided by the increasing government support and funding, along with the growing requirements of certain therapies.

 

The market is further being driven by the growing research and investments in novel drug delivery systems. Thus, the market is projected to grow at a CAGR of 11.6% during the forecast period of 2021-2026 to attain a value of nearly USD 391.5 billion by 2026.

 

Global Nanomedicine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Demand for Nanomedicines to Augment the Market Growth

The increase in the demand for nanomedicines can be attributed to the rapidly increasing applications of nanomaterials like nanocapsules as well as nanotubes in drug delivery systems. The demand for nanomedicines is further aided by the increase in the incidences of cancer and cardiovascular diseases, leading to the growth of public and private investments in nanomedicine research and advancements in biodegradable nanoparticles. The cost-effectiveness and fewer side-effects of these therapies are also major drivers of the nanomedicine industry growth.

 

North America to be a Significant Regional Market for Nanomedicine with the Asia Pacific Being One of the Fastest Growing Markets

Due to substantial government spending on nanomedicine research in the United States, the North American nanomedicine industry is expected to be one of the leading markets for nanomedicine in the forecast period of 2021-2026. The increased availability of patented nanomedicine items is credited with the region's growth. In addition to a well-developed healthcare infrastructure and a significant incidence of cancer, nanomedicine is easily accessible in this region, which has aided the market growth further.

The large geriatric population in the Asia Pacific is witnessing high incidence rates of cancer and cardiovascular diseases, which is expected to boost the nanomedicine market in the region. The regional market is expected to be one of the fastest growing markets for nanomedicine. The market growth in the Asia Pacific is expected to be aided by the increase in research grants to tackle life-threatening diseases, with countries like China and Japan leading the way.

 

Nanomedicine: Industry Definition and Segmentation

Nanomedicine is a segment of nanotechnology that is used to diagnose, treat, monitor, and regulate biological systems. It improves medicine delivery by manipulating materials at the nanoscale. As a result, nanomedicine has aided in the treatment of a variety of illnesses.

Nanomedicine is still in its infancy, with numerous items under development. Nanobiotix has identified 230 nanomedicine products that are either marked or in the trial phase. Out of the 230 products, 49 are in the market, and 122 are in the clinical trial phases, either in Phase II or Phase III trials.

Based on product type, the market can be segmented into:

  • Therapeutics
  • Regenerative Medicine
  • In-Vitro Diagnostics
  • In-Vivo Diagnostics
  • Vaccines

By application, the market is categorised into:

  • Clinical Oncology
  • Infectious Diseases
  • Clinical Cardiology
  • Orthopaedics
  • Others

On the basis of nanomolecule type, the industry is categorised into:

  • Nanoparticles and Quantum Dots
    • Metal and Metal Compounds
    • Liposomes
    • Polymer and Polymer Drug Conjugate
    • Hydrogel Nanoparticles
    • Dendrimers
    • Inorganic Nanoparticles
  • Nanoshells
  • Nanotubes
  • Nanodevices

The major regional markets of nanomedicine are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Increasing Focus on Technological Advancements for Improved Healthcare Services to Bolster the Growth of the Nanomedicine Industry

Currently, the healthcare sector is one of the most important areas where nanotechnology has made significant progress in the detection and treatment of chronic diseases such as cancer, heart disease, and other disorders. Firms researching patch technologies have attracted significant financing as healthcare companies focus on transdermal insulin administration as the industry's emphasis is moving toward transdermal medication delivery. Further, the tailored medication delivery method is being emphasised heavily in order to reduce the risk of side effects. Bypassing the body's defence mechanisms, this method provides reachability with increased efficacy and minimum degradation. Such technological developments and investments are likely to propel the growth of the market in the coming years.

 

Key Industry Players in the Global Nanomedicine Market

The report gives a detailed analysis of the following key players in the global nanomedicine market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Arrowhead Pharmaceuticals, Inc.
  • Nanospectra Biosciences, Inc.
  • Ablynx N.V.
  • AMAG Pharmaceuticals, Inc.
  • Celgene Corporation
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product Type, Application, Nanomolecule Type, Region
Breakup by Product Type Therapeutics, Regenerative Medicine, In-Vitro Diagnostics, In-Vivo Diagnostics, Vaccines
Breakup by Application Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopaedics, Others
Breakup by Nanomolecule Type Nanoparticles and Quantum Dots, Nanoshells, Nanotubes, Nanodevices
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Arrowhead Pharmaceuticals, Inc., Nanospectra Biosciences, Inc., Ablynx N.V., AMAG Pharmaceuticals, Inc., Celgene Corporation, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Nanomedicine Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Nanomedicine Historical Market (2016-2020) 
    8.3    Global Nanomedicine Market Forecast (2021-2026)
    8.4    Global Nanomedicine Market by Product Type
        8.4.1    Therapeutics
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Regenerative Medicine
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    In-Vitro Diagnostics
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
        8.4.4    In-Vivo Diagnostics
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2016-2020)
            8.4.4.3    Forecast Trend (2021-2026)
        8.4.5    Vaccines
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2016-2020)
            8.4.5.3    Forecast Trend (2021-2026)
    8.5    Global Nanomedicine Market by Application
        8.5.1    Clinical Oncology
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Infectious Diseases
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Clinical Cardiology
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
        8.5.4    Orthopaedics
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2016-2020)
            8.5.4.3    Forecast Trend (2021-2026)
        8.5.5    Others
    8.6    Global Nanomedicine Market by Nanomolecule Type
        8.6.1    Nanoparticles and Quantum Dots
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
                8.6.1.3.1    Metal and Metal Compounds
                8.6.1.3.2    Liposomes
                8.6.1.3.3    Polymer and Polymer Drug Conjugate
                8.6.1.3.4    Hydrogel Nanoparticles
                8.6.1.3.5    Dendrimers
                8.6.1.3.6    Inorganic Nanoparticles
        8.6.2    Nanoshells
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    Nanotubes
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
        8.6.4    Nanodevices
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2016-2020)
            8.6.4.3    Forecast Trend (2021-2026)
    8.7    Global Nanomedicine Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Arrowhead Pharmaceuticals, Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Nanospectra Biosciences, Inc.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Ablynx N.V.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    AMAG Pharmaceuticals, Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Celgene Corporation
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Nanomedicine Market: Key Industry Highlights, 2016 and 2026
2.    Global Nanomedicine Historical Market: Breakup by Product Type (USD Billion), 2016-2020
3.    Global Nanomedicine Market Forecast: Breakup by Product Type (USD Billion), 2021-2026
4.    Global Nanomedicine Historical Market: Breakup by Application (USD Billion), 2016-2020
5.    Global Nanomedicine Market Forecast: Breakup by Application (USD Billion), 2021-2026
6.    Global Nanomedicine Historical Market: Breakup by Nanomolecule Type (USD Billion), 2016-2020
7.    Global Nanomedicine Market Forecast: Breakup by Nanomolecule Type (USD Billion), 2021-2026
8.    Global Nanomedicine Historical Market: Breakup by Region (USD Billion), 2016-2020
9.    Global Nanomedicine Market Forecast: Breakup by Region (USD Billion), 2021-2026
10.    North America Nanomedicine Historical Market: Breakup by Country (USD Billion), 2016-2020
11.    North America Nanomedicine Market Forecast: Breakup by Country (USD Billion), 2021-2026
12.    Europe Nanomedicine Historical Market: Breakup by Country (USD Billion), 2016-2020
13.    Europe Nanomedicine Market Forecast: Breakup by Country (USD Billion), 2021-2026
14.    Asia Pacific Nanomedicine Historical Market: Breakup by Country (USD Billion), 2016-2020
15.    Asia Pacific Nanomedicine Market Forecast: Breakup by Country (USD Billion), 2021-2026
16.    Latin America Nanomedicine Historical Market: Breakup by Country (USD Billion), 2016-2020
17.    Latin America Nanomedicine Market Forecast: Breakup by Country (USD Billion), 2021-2026
18.    Middle East and Africa Nanomedicine Historical Market: Breakup by Country (USD Billion), 2016-2020
19.    Middle East and Africa Nanomedicine Market Forecast: Breakup by Country (USD Billion), 2021-2026
20.    Global Nanomedicine Market Structure

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 11.6% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach nearly USD 391.5 billion by 2026.

The major drivers of the industry, such as emerging technologies for drug delivery, increase in adoption of nanomedicine across varied applications, rise in government support and funding, growth in the need for therapies with fewer side effects, and cost-effectiveness of therapies, are expected to aid the market growth.

The key market trends guiding the growth of the industry include out-licensing of nanodrugs and growth of the healthcare facilities.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading product types of nanomedicine in the industry are therapeutics, regenerative medicine, in-vitro diagnostics, in-vivo diagnostics, and vaccines.

The major application segment in the market are clinical oncology, infectious diseases, clinical cardiology, and orthopaedics, among others.

The significant nanomolecule types in the industry are nanoparticles and quantum dots, nanoshells, nanotubes, and nanodevices.

The major players in the industry are Arrowhead Pharmaceuticals, Inc., Nanospectra Biosciences, Inc., Ablynx N.V., AMAG Pharmaceuticals, Inc., and Celgene Corporation, among others.

Analyst Review

The global nanomedicine market was driven by the emerging technologies for drug delivery. Aided by the growth in research and investments in novel drug delivery systems, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 11.6%. The market is projected to reach USD 391.5 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on product type, the nanomedicine industry can be segmented broadly into therapeutics, regenerative medicine, in-vitro diagnostics, in-vivo diagnostics, and vaccines. By application, the market is divided into clinical oncology, infectious diseases, clinical cardiology, and orthopaedics, among others. On the basis of nanomolecule type, the industry is categorised into nanoparticles and quantum dots, nanoshells, nanotubes, and nanodevices. The major regional markets for nanomedicine are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Arrowhead Pharmaceuticals, Inc., Nanospectra Biosciences, Inc., Ablynx N.V., AMAG Pharmaceuticals, Inc., and Celgene Corporation, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER